重型抑郁症(MDD)治疗药 沃替西汀(vortioxetine)是治疗抑郁症的新药,由丹麦灵北制药(Lundbeck)和日本武田制药(Takeda)联合研发,于2013年9月30日由美国食品药品监督管理局(FDA)批准上市,商品名Brintellix,用于重型抑郁症(MDD)的治疗。
Vortioxetine is used to cure depression as a new drug, it was co-developmented by Lundbeck and Takeda, and it was approveled by FDA on September, 30, 2013. Business name is Brintellix, for the treatment of major depressive disorder.
上海清松制药有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!